Application of Ptbp1 inhibitor in preventing and/or treating nervous system diseases related to functional neuron death
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CENT FOR EXCELLENCE IN BRAIN SCI & INTELLIGENCE TECH CHINESE ACAD OF SCI
- Publication Date
- 2021-03-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biomedicine. More specifically, the present invention relates to the use of Ptbp1 inhibitors in the prevention and / or treatment of neurological diseases related to functional neuron death. Background technique
[0002] Parkinson's disease (PD) is a severe neurodegenerative disorder characterized by the loss of dopamine neurons in the substantia nigra of the midbrain. Previous studies have achieved direct reprogramming of astrocytes to dopamine neurons in vitro and in animal models by simultaneously overexpressing several transcription factors. However, Ptbp1-mediated neuronal reprogramming in vivo has not been reported so far.
[0003] At present, the main treatment for Parkinson's disease is the medicine represented by levodopa preparation. At the same time, surgical treatment can also improve symptoms to a certain extent. It should be pointed out that all these means can only partially alleviate the condition...